Literature DB >> 15194870

Elevated adrenomedullin mRNA in lymphoblastoid cells from schizophrenic patients.

Chia-Hsing Huang1, Mao-Liang Chen, Yu-Lin Tsai, Ming-Ta Tsai, Chia-Hsiang Chen.   

Abstract

Adrenomedullin (ADM) is a 52 amino acid peptide with multiple physiological functions and wide tissue distributions including brain. Recently, elevated plasma levels of ADM were found in patients with schizophrenia, bipolar affective disorder and autism, suggesting the involvement of ADM in the pathophysiology of mental diseases. Using real-time quantitative PCR, we compared the ADM mRNA levels in lymphoblastoid cell lines between schizophrenic patients and controls. Male but not female schizophrenia patients had 2- to 3-fold higher ADM mRNA levels than controls (p<0.01). Our data support that ADM may be associated with the pathophysiology of schizophrenia, although the cause of the association needs further study.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194870     DOI: 10.1097/01.wnr.0000132202.69212.79

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  4 in total

1.  Lymphoblastoid cell lines models of drug response: successes and lessons from this pharmacogenomic model.

Authors:  J Jack; D Rotroff; A Motsinger-Reif
Journal:  Curr Mol Med       Date:  2014       Impact factor: 2.222

2.  Genetic signatures of heroin addiction.

Authors:  Shaw-Ji Chen; Ding-Lieh Liao; Tsu-Wang Shen; Hsin-Chou Yang; Kuang-Chi Chen; Chia-Hsiang Chen
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

3.  Role of SIRT1/PGC-1α in mitochondrial oxidative stress in autistic spectrum disorder.

Authors:  Xiaosong Bu; Xiaomei Lu; Li Yang; Xiaoyan Xu; Juan Wang; Jiulai Tang
Journal:  Neuropsychiatr Dis Treat       Date:  2017-06-23       Impact factor: 2.570

4.  Increased gene expression of FOXP1 in patients with autism spectrum disorders.

Authors:  Wei-Hsien Chien; Susan Shur-Fen Gau; Chun-Houh Chen; Wen-Che Tsai; Yu-Yu Wu; Po-Hsu Chen; Chi-Yung Shang; Chia-Hsiang Chen
Journal:  Mol Autism       Date:  2013-07-01       Impact factor: 7.509

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.